Product Information
MYFEMBREE 40 MG-1 MG-0.5 MG TB is a brand product labeled by Sumitomo Pharma America, Inc., priced at $45.2600 per EA under NDC 72974041501. Its NADAC has been published 193 times since Oct 19, 2022.
MYFEMBREE 40 MG-1 MG-0.5 MG TB
relugolix, estradiol hemihydrate, and norethindrone acetateStrength
1; .5; 40 mg/1; mg/1; mg/1
Manufacturer
Sumitomo Pharma America, Inc.NDC
72974041501
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ESTRADIOL HEMIHYDRATE; NORETHINDRONE ACETATE; RELUGOLIXApproval Type
New Drug (NDA)
FDA Application
NDA214846On Market Since
5/26/2021
Pharmacological Classes
Price Statistics
The NADAC for MYFEMBREE 40 MG-1 MG-0.5 MG TB has been published 193 times since Oct 19, 2022, and over the history we have for it it has risen 26.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $45.2600 per EA |
|---|---|
| All-time high | $45.3620 (May 13, 2026) |
| All-time low | $35.6728 (Oct 19, 2022) |
| 52-week high | $45.3620 |
| 52-week low | $42.7888 |
| Median price | $40.1348 |
| Average price | $40.5266 |
| Largest weekly change | +7.5% (Jan 10, 2024) |
| Weeks tracked | 193 |
| Tracking since | Oct 19, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the relugolix, estradiol hemihydrate, and norethindrone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MYFEMBREE 40 MG-1 MG-0.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for MYFEMBREE 40 MG-1 MG-0.5 MG TB, manufactured by Sumitomo Pharma America, Inc., is $45.2600 per EA (NDC 72974041501), effective Jun 24, 2026.
How has the price of MYFEMBREE 40 MG-1 MG-0.5 MG TB changed over time?
Over the history we have for it, the NADAC for MYFEMBREE 40 MG-1 MG-0.5 MG TB has risen 26.9%. It has been tracked across 193 weekly CMS publications since Oct 19, 2022.
What are the highest and lowest recorded NADAC prices for MYFEMBREE 40 MG-1 MG-0.5 MG TB?
Since Oct 19, 2022, the NADAC for MYFEMBREE 40 MG-1 MG-0.5 MG TB has ranged from a low of $35.6728 (Oct 19, 2022) to a high of $45.3620 (May 13, 2026), with a median of $40.1348 per EA.
Are there cheaper alternatives to MYFEMBREE 40 MG-1 MG-0.5 MG TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MYFEMBREE 40 MG-1 MG-0.5 MG TB, so no direct lower-cost alternative is listed.
Who manufactures MYFEMBREE 40 MG-1 MG-0.5 MG TB?
MYFEMBREE 40 MG-1 MG-0.5 MG TB (NDC 72974041501) is labeled by Sumitomo Pharma America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification